Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most

Young adults taking Truvada for pre-exposure prophylaxis (PrEP) experienced a modest decrease in bone mineral density early on, but this stabilised after a year and those who stopped

Published
11 hours ago
By
Liz Highleyman
European CHMP Adopts Positive Opinion on Truvada® for Pre-Exposure Prophylaxis

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s Type II variation application for once-daily Truvada® (emtricitabine 200 mg/tenofovir disoproxil 245 mg) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk, a strategy known as pre-exposure prophylaxis, or PrEP.

Published
22 July 2016
From
Gilead press release
Australia adopts ambitious plan to use PrEP to ‘virtually eliminate’ HIV by 2020

Australia plans an ambitious programme of pre-exposure prophylaxis (PrEP) provision for gay men at high risk of HIV, with the aim of ‘virtually eliminating’ HIV in the

Published
21 July 2016
By
Gus Cairns
HIV Drug Pricing Protest Interrupts PrEP Session at AIDS 2016

Protesters against the high cost of antiretroviral drugs joined forces and marched together today, interrupting a research presentation today at the 21st International AIDS Conference (AIDS 2016).

Published
21 July 2016
From
BETA blog
PrEP can further reduce the risk of HIV infection after a partner starts treatment

Offering Truvada pre-exposure prophylaxis (PrEP) to the HIV-negative partner in a serodiscordant couple during the first six months after the HIV-positive partner starts antiretroviral therapy (ART) can

Published
21 July 2016
By
Liz Highleyman
Young gay men can do well on PrEP, but may need more support

Young gay and bisexual men had good adherence to Truvada for pre-exposure prophylaxis (PrEP) during the first few months of a demonstration project with close monitoring, but adherence

Published
21 July 2016
By
Liz Highleyman
Comprehensive services for sex workers reduce detectable viral load, but enhanced ARV services provide no extra benefit

A randomised trial in female sex workers in Zimbabwe, offering enhanced access to HIV treatment and pre-exposure prophylaxis (PrEP), has failed to show that the extra services

Published
19 July 2016
By
Roger Pebody
PrEP use exceeds 79,000 in US pharmacy survey, but some groups lagging behind

More than 79,000 people in the US have started Truvada for pre-exposure prophylaxis (PrEP) over the past four years, according to the latest results from a

Published
19 July 2016
By
Liz Highleyman
With 20 Billion Condoms and 3 Million People on PrEP, Could We Reach the UNAIDS HIV Prevention Goal in 5 Years?

Can we reduce the total number of new HIV infections that happen worldwide every year, from 2 million to 500,000—in five years?

Published
19 July 2016
From
BETA blog
PrEP researchers now focusing on the best ways to get PrEP to people who need it

Speaking to a meeting on pre-exposure prophylaxis (PrEP) yesterday, ahead of the 21st International AIDS Conference (AIDS 2016), Chris Beyrer, president of the International AIDS Society,

Published
18 July 2016
By
Roger Pebody
← First12345...90Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close